๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Adjustment to perceived ovarian cancer risk

โœ Scribed by Kathleen Franco; Jerome Belinson; Graham Casey; Sarah Plummer; Marijo Tamburrino; Ericka Tung

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
90 KB
Volume
9
Category
Article
ISSN
1057-9249

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Managing hereditary ovarian cancer risk
Managing hereditary ovarian cancer risk
โœ Andrew Berchuck; Joellen M. Schildkraut; Jeffrey R. Marks; P. Andrew Futreal ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB ๐Ÿ‘ 2 views

Ovarian cancer is the fourth leading cause of cancer deaths in American women. About 10% of cases are thought to have a hereditary basis, and family history is the strongest known risk factor. In the past, prophylactic oophorectomy has been advocated for women with two or more affected first-degree

Oral contraceptives and risk of ovarian
Oral contraceptives and risk of ovarian cancer
โœ Walter C. Willett; Christopher Bain; Charles H. Hennekens; Bernard Rosner; Frank ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 329 KB ๐Ÿ‘ 2 views
CYP17 promotor polymorphism and ovarian
CYP17 promotor polymorphism and ovarian cancer risk
โœ Amanda B. Spurdle; Xiaoqing Chen; Mohammed Abbazadegan; Nicholas Martin; Soo-Kea ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 55 KB ๐Ÿ‘ 1 views

The CYP17 gene encodes the cytochrome P450c17โฃ enzyme, which functions at 2 different points in the steroid biosynthesis pathway, and is considered a candidate susceptibility gene for endocrine-related tumors. A T to C substitution polymorphism exists in the 5 promoter region of this gene, and creat